$NUTX

iGambit, Inc.

CIK:0001479681|SEC Filings

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Revenue:
Total revenue	$ 210,752	$ 243,985	$ 427,237	$ 455,774
Operating costs and expenses:
Payroll	42,751	36,284	84,190	71,144
Contract services	1,082	61,109	61,614	99,764
Medical supplies	5,342	4,812	9,351	8,613
Depreciation and amortization	5,317	5,248	10,809	10,340
Other	14,981	11,608	28,264	22,651
Total operating costs and expenses	69,473	119,061	194,228	212,512
Gross profit	141,279	124,924	233,009	243,262
Corporate and other costs:
Stock-based compensation	2,884	78,747	(1,031)	106,389
General and administrative expenses	16,677	12,498	31,057	22,533
Total corporate and other costs	19,561	91,245	30,026	128,922
Operating income	121,718	33,679	202,983	114,340
Interest expense, net	4,671	5,678	9,353	11,798
Other expense	(38)	4,269	(15)	7,594
Income before taxes	117,085	23,732	193,645	94,948
Income tax expense	20,768	7,588	34,565	27,998
Net income	96,317	16,144	159,080	66,950
Less: net income attributable to noncontrolling interests	30,475	33,841	46,431	63,430
Net income attributable to Nutex Health Inc.	$ 65,842	$ (17,697)	$ 112,649	$ 3,520
Earnings per common share:
Basic earnings (loss) per common share (in dollars per share)	$ 9.58	$ (2.95)	$ 16.26	$ 0.60
Diluted earnings (loss) per common share (in dollars per share)	$ 9.38	$ (2.95)	$ 15.87	$ 0.55
Hospital division
Revenue:
Total revenue	$ 201,852	$ 236,302	$ 409,422	$ 440,249
Population health management division
Revenue:
Total revenue	$ 8,900	$ 7,683	$ 17,815	$ 15,525

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash flows from operating activities:
Net income	$ 159,080	$ 66,950
Adjustment to reconcile net income to net cash from operating activities:
Depreciation and amortization	10,809	10,340
Stock-based compensation expense	(1,031)	106,389
Changes to deferred taxes	1,775	(4,865)
Debt accretion expense	44	504
Non-cash effect of change in estimate	(52,319)	0
Changes in operating assets and liabilities:
(Increase)/Decrease in Inventories	(1,341)	575
(Increase)/Decrease in Prepaid expenses and other current assets	4,122	(8,640)
(Increase)/Decrease in Operating right-of-use assets	805	121
Increase/(Decrease) in Operating lease liabilities	(728)	194
Increase/(Decrease) in Accrued arbitration expenses	14,729	21,043
Increase/(Decrease) in Accrued income tax expense	3,139	(18,169)
Increase/(Decrease) in Accrued expenses and other current liabilities	3,408	2,180
Net cash provided by operating activities	109,718	78,222
Cash flows from investing activities:
Acquisitions of property and equipment	(3,741)	(815)
Proceeds from restricted short-term investment	0	2,941
Cash related to asset acquisition	0	(1,994)
Net cash provided by (used in) investing activities	(3,741)	132
Cash flows from financing activities:
Proceeds from lines of credit	0	4,606
Proceeds from notes payable	0	258
Repayments of lines of credit	(642)	(301)
Repayments of notes payable	(2,953)	(5,697)
Repayments of finance leases	(3,317)	(2,593)
Proceeds from exercise of warrants	75	0
Cash related to stock repurchases and retirements	(50,688)	0
Members' contributions	1,405	242
Members' distributions	(28,620)	(18,776)
Net cash used in financing activities	(84,740)	(22,261)
Net change in cash, cash equivalents, and restricted cash	21,237	56,093
Cash and cash equivalents - beginning of the period	205,208	96,733
Restricted cash - beginning of period	297	0
Cash and cash equivalents and restricted cash - beginning of period	185,871	40,640
Cash and cash equivalents - end of period	185,574	40,640
Restricted cash - end of period	1,900	0
Cash and cash equivalents and restricted cash - end of period	207,108	96,733
Nonrelated Party
Changes in operating assets and liabilities:
(Increase)/Decrease in Accounts receivable	(32,235)	(116,768)
Increase/(Decrease) in Accounts payable	(4,067)	19,334
Related Party
Changes in operating assets and liabilities:
(Increase)/Decrease in Accounts receivable	953	(2,135)
Increase/(Decrease) in Accounts payable	$ 2,575	$ 1,169

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current assets:
Cash and cash equivalents	$ 205,208	$ 185,574
Restricted cash	1,900	297
Inventories	4,207	2,866
Prepaid expenses and other current assets	17,635	24,656
Total current assets	585,650	538,811
Property and equipment, net (accumulated depreciation of 33,598 and 31,696 as of June 30, 2026 and December 31, 2025, respectively)	95,702	94,581
Operating lease right-of-use assets	26,150	26,955
Financing lease right-of-use assets	219,067	222,367
Intangible assets, net	20,580	21,230
Goodwill, net	13,919	13,919
Other assets	3,561	662
Total assets	964,629	918,525
Current liabilities:
Lines of credit	98	740
Current portion of long-term debt	8,496	13,336
Operating lease liabilities, current portion	2,238	2,152
Financing lease liabilities, current portion	7,271	7,077
Accrued arbitration expenses	49,668	49,743
Accrued income tax expense	4,006	867
Accrued stock-based compensation	4,854	8,256
Accrued expenses and other current liabilities	30,629	26,773
Total current liabilities	117,220	157,911
Long-term debt, net	31,105	29,174
Non-current operating lease liabilities, net	29,223	30,037
Non-current financing lease liabilities, net	268,905	268,877
Deferred tax liabilities	10,864	9,089
Total liabilities	457,317	495,088
Commitments and contingencies (Note 10)
Equity:
Common stock, $0.001 par value; 950,000,000 shares authorized; 6,951,622 and 5,511,452 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively	7	7
Additional paid-in capital	567,847	615,627
Accumulated deficit	(173,538)	(286,187)
Nutex Health Inc. equity	394,316	329,447
Noncontrolling interests	112,996	93,990
Total equity	507,312	423,437
Total liabilities and equity	964,629	918,525
Nonrelated Party
Current assets:
Accounts receivable	351,675	319,440
Current liabilities:
Accounts payable	4,281	45,863
Related Party
Current assets:
Accounts receivable	5,025	5,978
Current liabilities:
Accounts payable	$ 5,679	$ 3,104